The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Assessment of tumour infiltrating subpopulations and pathological complete response using multiplex immunohistochemistry and digital pathology in early HER2+ breast cancer.
 
Camille Hurley
No Relationships to Disclose
 
Laetitia Lacroix
No Relationships to Disclose
 
Katherine Sheehan
No Relationships to Disclose
 
Mairi Lucas
No Relationships to Disclose
 
Rachel Buckley
No Relationships to Disclose
 
Anna Blümel
No Relationships to Disclose
 
Sinead Toomey
No Relationships to Disclose
 
Bryan T. Hennessy
No Relationships to Disclose
 
John Crown
Employment - OncoAssure; OncoMark
Stock and Other Ownership Interests - OncoAssure; OncoMark
Honoraria - MSD Oncology; Novartis Ireland Ltd.; Pfizer; Roche
Consulting or Advisory Role - G1 Therapeutics; MSD Oncology; Novartis Ireland Ltd.; Pfizer; Puma Biotechnology; Roche
Speakers' Bureau - Pfizer
Research Funding - Boehringer Ingelheim (Inst); Eisai (Inst); Puma Biotechnology (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - WO2020011770 (A1) - A method of predicting response to treatment in cancer patients
Travel, Accommodations, Expenses - Abbvie; Daiichi Sankyo Europe GmbH; MSD; Novartis Ireland Ltd.; Pfizer; Roche
 
Catherine Sautes-Fridman
No Relationships to Disclose
 
Darran O'Connor
No Relationships to Disclose